Company Information

AAREY DRUGS & PHARMACEUTICALS LTD.

NSE : AAREYDRUGSBSE : 524412ISIN CODE : INE198H01019Industry : Pharmaceuticals & DrugsHouse : Aarey
BSE54.921.47 (+2.75 %)
PREV CLOSE ( ) 53.45
OPEN PRICE ( ) 55.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 29894
TODAY'S LOW / HIGH ( )53.50 55.50
52 WK LOW / HIGH ( )26.82 68
NSE54.401.15 (+2.16 %)
PREV CLOSE( ) 53.25
OPEN PRICE ( ) 53.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 122637
TODAY'S LOW / HIGH( ) 51.05 55.55
52 WK LOW / HIGH ( )27 68
ChairmanMihir R Ghatalia
Managing DirectorMihir R Ghatalia
Company SecretaryPreeti Paresh Rathi
Executive DirectorNimit R Ghatalia
Additional DirectorBina Ghatalia
Non Executive Independent DirectorChetan Kiritbhai Mehta
Lalit R Tulsiani
Anil Mandal
Incorporation Year : 15-05 1990

Registered Office :

Address : E 34,M I D C ,Tarapur Boisar Thane,
Maharashtra-401506 .

Phone : 022-23455543

Email :  info@aareydrugs.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.